Catalyst Pharmaceuticals, Inc.
CPRXNASDAQHealthcare● Active
$31.28
+$0.01(+0.03%)
Market Cap$3.8B
P/E Ratio—
52W High$32.56
52W Low$19.05
Catalyst Pharmaceuticals, Inc.（CPRX）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CPRX · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.21B | $0.16B | $0.07B | $0.08B | $0.04B |
| Depreciation & Amort. | $0.04B | $0.04B | $0.03B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.02B | $0.02B | $0.01B | $0.01B | $0.01B |
| Change in Working Capital | ($0.06B) | $0.03B | ($0.04B) | $0.01B | $0.01B |
| Net Cash from Operations | $0.21B | $0.24B | $0.14B | $0.12B | $0.06B |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.08B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | ($0.01B) | ($0.01B) | ($0.01B) |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.02B | $0.00B |
| Net Cash from Investing | ($0.00B) | ($0.00B) | ($0.29B) | $0.01B | ($0.01B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.03B) | ($0.00B) | $0.00B | ($0.01B) | ($0.01B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | ($0.02B) | $0.14B | ($0.01B) | $0.00B | ($0.01B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.21B | $0.24B | $0.06B | $0.12B | $0.06B |
| FCF Margin %(computed) | 35.42% | 48.65% | 15.53% | 54.16% | 42.14% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Catalyst Pharmaceuticals, Inc.
关于Catalyst Pharmaceuticals, Inc.（CPRX）现金流量表
Catalyst Pharmaceuticals, Inc. 2025财年经营活动现金流$0.21B，自由现金流$0.21B（FCF利润率35.42%），资本支出($0.00B)。
常见问题
CPRX · 4 问Catalyst Pharmaceuticals, Inc. 2025财年自由现金流$0.21B，同比down12.8%。
CPRX free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10